Spectrum of Clinical Variability with SEPT9 Gene Mutation in Hereditary Neuralgic Amyotrophy: Understanding the Pathogenesis Using Molecular Dynamics Simulation Study.


Journal

Neurology India
ISSN: 1998-4022
Titre abrégé: Neurol India
Pays: India
ID NLM: 0042005

Informations de publication

Date de publication:
01 Sep 2024
Historique:
received: 12 10 2019
accepted: 18 08 2020
medline: 21 10 2024
pubmed: 21 10 2024
entrez: 21 10 2024
Statut: ppublish

Résumé

Hereditary Neuralgic Amyotrophy (HNA) is an autosomal dominant disorder characterized by episodes of severe pain and amyotrophy affecting the brachial plexus as well as other sites. Mutations in the SEPTIN9 gene have been identified as genetic abnormality for HNA. Although the genetic mutations are known, their pathogenesis for the causation of this disorder is not exactly elucidated. In this study, we have investigated the phenotypic and genetic features in a large pedigree with HNA. We report the clinical spectrum and genetic analysis of a family with 9 affected members. Clinical heterogeneity has been reported in the individuals having mutations in SEPTIN9 gene. After taking informed consent, we have done genetic analysis of 6 affected and 4 unaffected members of the family to identify the molecular abnormalities of SEPTIN9 gene. Genetic analysis has identified the presence of NM_001113491.2:p.Arg106Trp mutation in SEPTIN9 gene. The same mutation has been identified in 6 affected members of the family. Molecular simulation study has revealed that the mutation has significantly altered the conformation of septin-9 protein, thereby impairing the microtubule binding and bundling ability. Although the affected members shared a common recurrent mutation, they have a wide spectrum of clinical variability. This may be due to the variable penetrance of the mutation and different epigenetic influences in the family. This is the first genetically confirmed case series of HNA reported from India.

Sections du résumé

BACKGROUND BACKGROUND
Hereditary Neuralgic Amyotrophy (HNA) is an autosomal dominant disorder characterized by episodes of severe pain and amyotrophy affecting the brachial plexus as well as other sites. Mutations in the SEPTIN9 gene have been identified as genetic abnormality for HNA. Although the genetic mutations are known, their pathogenesis for the causation of this disorder is not exactly elucidated.
OBJECTIVE OBJECTIVE
In this study, we have investigated the phenotypic and genetic features in a large pedigree with HNA.
METHODS METHODS
We report the clinical spectrum and genetic analysis of a family with 9 affected members. Clinical heterogeneity has been reported in the individuals having mutations in SEPTIN9 gene. After taking informed consent, we have done genetic analysis of 6 affected and 4 unaffected members of the family to identify the molecular abnormalities of SEPTIN9 gene.
RESULTS AND CONCLUSIONS CONCLUSIONS
Genetic analysis has identified the presence of NM_001113491.2:p.Arg106Trp mutation in SEPTIN9 gene. The same mutation has been identified in 6 affected members of the family. Molecular simulation study has revealed that the mutation has significantly altered the conformation of septin-9 protein, thereby impairing the microtubule binding and bundling ability. Although the affected members shared a common recurrent mutation, they have a wide spectrum of clinical variability. This may be due to the variable penetrance of the mutation and different epigenetic influences in the family. This is the first genetically confirmed case series of HNA reported from India.

Identifiants

pubmed: 39428775
doi: 10.4103/neurol-india.NI_823_19
pii: 02223311-202409000-00016
doi:

Substances chimiques

Septins EC 3.6.1.-
SEPTIN9 protein, human EC 3.6.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1021-1026

Informations de copyright

Copyright © 2024 Copyright: © 2024 Neurology India, Neurological Society of India.

Références

Taylor RA. Heredofamilial mononeuritis multiplex with brachial predilection. Brain 1960;83:113–37.
van Alfen N, van Engelen BGM. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 2006;129:438–50.
Meuleman J, Kuhlenbäumer G, Schirmacher A, Wehnert M, De Jonghe P, De Vriendt E, et al. Genetic refinement of the hereditary neuralgic amyotrophy (HNA) locus at chromosome 17q25. Eur J Hum Genet 1999;7:920–7.
Kuhlenbäumer G, Hannibal MC, Nelis E, Schirmacher A, Verpoorten N, Meuleman J, et al. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet 2005;37:1044–6.
Hall PA, Russell SH. The pathobiology of the septin gene family. J Pathol 2004;204:489–505.
Collie AMB, Landsverk ML, Ruzzo E, Mefford HC, Buysse K, Adkins JR, et al. Non-recurrent SEPT9 duplications cause hereditary neuralgic amyotrophy. J Med Genet 2010;47:601–7.
Klein CJ, Barbara DW, Sprung J, Dyck PJ, Weingarten TN. Surgical and postpartum hereditary brachial plexus attacks and prophylactic immunotherapy. Muscle Nerve 2013;47:23–7.
Yang J, Zhang Y. Protein structure and function prediction using I-TASSER. Curr Protoc Bioinform 2015;52:5.8.1-15. doi: 10.1002/0471250953.bi0508s52.
Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. GROMACS: Fast, flexible, and free. J Comput Chem 2005;26:1701–18.
Wolfram Research, Inc., Mathematica, Version 2.2, Champaign, IL 1993.
Hoque R, Schwendimann RN, Kelley RE, Bien-Willner R, Sivakumar K. Painful brachial plexopathies in SEPT9 mutations: Adverse outcome related to comorbid states. J Clin Neuromuscul Dis 2008;9:379–84.
van Alfen N, van Engelen BG, Reinders JW, Kremer H, Gabreëls FJ. The natural history of hereditary neuralgic amyotrophy in the Dutch population: Two distinct types? Brain 2000;123(Pt 4):718–23.
Ueda M, Kawamura N, Tateishi T, Sakae N, Motomura K, Ohyagi Y, et al. Phenotypic spectrum of hereditary neuralgic amyotrophy caused by the SEPT9 R88W mutation. J Neurol Neurosurg Psychiatry 2010;81:94–6.
Bai X, Bowen JR, Knox TK, Zhou K, Pendziwiat M, Kuhlenbäumer G, et al. Novel septin 9 repeat motifs altered in neuralgic amyotrophy bind and bundle microtubules. 2013;203:895–905.

Auteurs

Amit Bhatti (A)

Department of Neurology, Seth GS Medical College and KEM Hospital, Acharya Donde Marg, Maharashtra, India.

Sangeeta Ravat (S)

Department of Neurology, Seth GS Medical College and KEM Hospital, Acharya Donde Marg, Maharashtra, India.

Karan Desai (K)

Department of Neurology, Seth GS Medical College and KEM Hospital, Acharya Donde Marg, Maharashtra, India.

Bipin R Shekhar (BR)

Department of Genetics, ICMR-National Institute for Research in Reproductive Health (ICMR-NIRRH), Jahangir Merwanji Street, Maharashtra, India.

Shyla R Menon (SR)

Department of Genetics, ICMR-National Institute for Research in Reproductive Health (ICMR-NIRRH), Jahangir Merwanji Street, Maharashtra, India.

Bajarang V Kumbhar (BV)

Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra, India.

Ambarish Kunwar (A)

Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra, India.

Neeraj Jain (N)

Department of Neurology, Seth GS Medical College and KEM Hospital, Acharya Donde Marg, Maharashtra, India.

Dhanjit K Das (DK)

Department of Genetics, ICMR-National Institute for Research in Reproductive Health (ICMR-NIRRH), Jahangir Merwanji Street, Maharashtra, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH